NPF
SRRA

Norris Perne & French’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Norris Perne & French’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,181
Closed -$318K – 147
2016
Q1 		$318K Buy
+1,181
New +$377K 0.07% 114

Other funds holding SRRA

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GT
Greenleaf Trust Kalamazoo, Michigan $10.2B AUM 2.09% 1-Year Est. Return

Norris Perne & French's SRRA Position: Q2 2016 in Review

Norris Perne & French sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q2 2016, closing a stake of 1,181 shares — an estimated $318K sold.

Norris Perne & French first reported a position in SRRA in Q1 2016 and held it in 1 quarter. The position peaked at $318K in Q1 2016. 44 funds tracked by Wall St. Rank hold SRRA as of Q2 2016.

  • Norris Perne & French reported no remaining Sierra Oncology, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
  • Norris Perne & French sold 1,181 Sierra Oncology, Inc. Common Stock shares in Q2 2016, an estimated $318K.
  • Norris Perne & French first reported a position in Sierra Oncology, Inc. Common Stock in Q1 2016 and held it in 1 quarter.
  • Norris Perne & French's Sierra Oncology, Inc. Common Stock position peaked at $318K in Q1 2016.
  • 44 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q2 2016.

Based on Norris Perne & French's 13F filing for Q2 2016, filed 25 Jul 2016.